Patents and Public Health : Legalising the Policy Thoughts in the Doha TRIPS Declaration of 14 November 2001
Do patents rules prevent countries from acquiring affordable medicines? A number of legal experts and governments have felt that the WTO, in particular the TRIPS Agreement, forces countries to favour patents over public health. The WTO sought to settle this dispute by concluding the Public Health De...
Saved in:
Superior document: | Munich Intellectual Property Law Center – MIPLC |
---|---|
: | |
Year of Publication: | 2009 |
Language: | English |
Series: | Munich Intellectual Property Law Center – MIPLC
|
Physical Description: | 1 electronic resource (292 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drugs, technologies and cyber markets / / guest editors, Karenza Moore and Angus Bancroft.
by: Sultan, Aysel,
Published: ([2021]) -
Food and drug regulation in an era of globalized markets / / edited by Sam F. Halabi.
Published: (2015.) -
Compulsory licensing for public health : a guide and model documents for implementation of the Doha Declaration paragraph 6 decision / / Frederick M. Abbott and Rudolf V. Van Puymbroeck.
by: Abbott, Frederick M.
Published: (2005.) -
The TRIPS agreement implementation in Brazil : : patents in the pharmaceutical area / / Viviane Yumy Mitsuuchi Kunisawa.
by: Kunisawa, Viviane Yumy Mitsuuchi,
Published: (2015) -
Patents in the Food Sector : A Retrospective with Special Emphasis on the TRIPs Agreement
by: Willnegger, Eva
Published: (2008)